MedTrace Logo

Web-based Acceptance and Commitment Therapy (ACT) Intervention for University Students

NCT07753837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2026-08-12

No results posted yet for this study

Summary

University students frequently experience psychological distress, reduced wellbeing, and academic challenges associated with the transition to higher education. This randomized controlled trial evaluated the effectiveness of a culturally adapted web-based intervention based on the principles of Acceptance and Commitment Therapy (ACT). Participants were randomly assigned to either an intervention group receiving an eight-session online mindfulness program or a wait-list control group. The intervention was designed to improve mindfulness, psychological flexibility, wellbeing, quality of life, and academic functioning. Outcomes were assessed using standardized self-report measures administered before and after the intervention. The study examined whether participation in the intervention resulted in significant improvements compared with the wait-list control condition.

Conditions

  • No Disease

Interventions

BEHAVIORAL

Web-based ACT intervention for University Students

Participants received an eight-session web-based intervention based on the principles of Acceptance and Commitment Therapy (ACT). The intervention was delivered online and included psychoeducation, mindfulness meditation practices, breathing exercises, experiential activities, values clarification, acceptance and cognitive defusion exercises, present-moment awareness, self-as-context activities, committed action tasks, and weekly home practice assignments. Each session was designed to enhance mindfulness, psychological flexibility, wellbeing, and quality of life among university students

Sponsors & Collaborators

  • National University of Modern Languages

    lead OTHER

Principal Investigators

  • Asia Mushtaq · National University of Modern Languages, Islamabad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-15
Primary Completion
2024-04-10
Completion
2024-08-19

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07753837 on ClinicalTrials.gov